Rights and permissions
About this article
Cite this article
Paclitaxel approved for first-line use in ovarian cancer in the UK. Inpharma Wkly. 1063, 22 (1996). https://doi.org/10.2165/00128413-199610630-00047
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199610630-00047